Literature DB >> 444403

Microenvironmental arginine depletion by macrophages in vivo.

G A Currie, L Gyure, L Cifuentes.   

Abstract

Since the tumour-selective cytotoxic activity of activated macrophages in vitro can be attributed to depletion of the culture medium of L-arginine by macrophage arginase, a series of experiments was designed to determine whether such a mechanism could operate in vivo. Extracellular fluid obtained from Gullino chambers within established tumours contained high levels of arginase, no detectable arginine and high levels of ornithine. When tumours were disaggregated into single-cell suspensions, arginase was readily detected within tumour macrophages but not within malignant cells. Inflammatory ascites induced in mice by Corynebacterium parvum was rich in arginase, depleted of L-arginine and cytotoxic in vitro to L5178Y and V79 cells. High levels of arginase in the ascites fluid were associated with resistance to challenge with syngeneic L5178Y cells. Lymph collected from the cisterna chyli in rats bearing a macrophage-rich sarcoma on the small bowel contained elevated levels of arginase, was depleted of arginine and contained increased concentrations of ornithine. We conclude that in sites of macrophage infiltration there is microenvironmental arginine depletion due to the action of arginase, and that arginase release could represent an important macrophage effector mechanism against a variety of targets, including malignant cells, virus-infected cells, fungi and parasites.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444403      PMCID: PMC2009995          DOI: 10.1038/bjc.1979.112

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Assessment of serum arginase activity in intestinal and hepatic schistosomiasis.

Authors:  K H Khalifa; T A Hafez; R Henry
Journal:  J Egypt Med Assoc       Date:  1976

2.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

3.  THE INTERSTITIAL FLUID OF SOLID TUMORS.

Authors:  P M GULLINO; S H CLARK; F H GRANTHAM
Journal:  Cancer Res       Date:  1964-06       Impact factor: 12.701

4.  ENZYMES OF ARGININE METABOLISM IN MAMMALIAN CELL CULTURE. I. REPRESSION OF ARGININOSUCCINATE SYNTHETASE AND ARGININOSUCCINASE.

Authors:  R T SCHIMKE
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

5.  Arginase, an antimitotic agent in tissue culture.

Authors:  I SIMON-REUSS
Journal:  Biochim Biophys Acta       Date:  1953-07

6.  Effects of intraperitoneally injected arginase on growth of mammary carcinoma implants in the mouse.

Authors:  O B WISWELL
Journal:  Proc Soc Exp Biol Med       Date:  1951-03

7.  Activated macrophages kill tumour cells by releasing arginase.

Authors:  G A Currie
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

8.  Suppression of in vitro cytotoxic response by macrophages due to induced arginase.

Authors:  J T Kung; S B Brooks; J P Jakway; L L Leonard; D W Talmage
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

9.  THE EFFECT OF ARGINASE ON THE RETARDATION OF TUMOUR GROWTH.

Authors:  S J BACH; D SWAINE
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640

10.  Differential arginine dependence and the selective cytotoxic effects of activated macrophages for malignant cells in vitro.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

View more
  22 in total

1.  Accelerate Healing of Severe Burn Wounds by Mouse Bone Marrow Mesenchymal Stem Cell-Seeded Biodegradable Hydrogel Scaffold Synthesized from Arginine-Based Poly(ester amide) and Chitosan.

Authors:  Bhagwat V Alapure; Yan Lu; Mingyu He; Chih-Chang Chu; Hongying Peng; Filipe Muhale; Yue-Liang Brewerton; Bruce Bunnell; Song Hong
Journal:  Stem Cells Dev       Date:  2018-10-23       Impact factor: 3.272

2.  L-arginine transport is increased in macrophages generating nitric oxide.

Authors:  R G Bogle; A R Baydoun; J D Pearson; S Moncada; G E Mann
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

3.  CTLA4-Ig inhibits allergic airway inflammation by a novel CD28-independent, nitric oxide synthase-dependent mechanism.

Authors:  Christine M Deppong; Amit Parulekar; Jonathan S Boomer; Traci L Bricker; Jonathan M Green
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

4.  Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages.

Authors:  Y Xia; J L Zweier
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

5.  Enhancement of macrophage microbicidal activity: supplemental arginine and citrulline augment nitric oxide production in murine peritoneal macrophages and promote intracellular killing of Trypanosoma cruzi.

Authors:  K A Norris; J E Schrimpf; J L Flynn; S M Morris
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

6.  Inhibition of herpes simplex virus multiplication by activated macrophages: a role for arginase?

Authors:  P Wildy; P G Gell; J Rhodes; A Newton
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

Review 7.  Amino acid auxotrophy as a system of immunological control nodes.

Authors:  Peter J Murray
Journal:  Nat Immunol       Date:  2016-02       Impact factor: 25.606

8.  T Cells Encountering Myeloid Cells Programmed for Amino Acid-dependent Immunosuppression Use Rictor/mTORC2 Protein for Proliferative Checkpoint Decisions.

Authors:  Lee-Ann Van de Velde; Chitra Subramanian; Amber M Smith; Luke Barron; Joseph E Qualls; Geoffrey Neale; Adolfo Alfonso-Pecchio; Suzanne Jackowski; Charles O Rock; Thomas A Wynn; Peter J Murray
Journal:  J Biol Chem       Date:  2016-11-30       Impact factor: 5.157

Review 9.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

Review 10.  Arginine deprivation as a targeted therapy for cancer.

Authors:  L Feun; M You; C J Wu; M T Kuo; M Wangpaichitr; S Spector; N Savaraj
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.